Nils-Göran Pettersson

Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets.

Stick Tech Oy engages in the development, manufacture, and marketing of products for dental reinforcements. It offers everStickC&B, a glass fibre reinforcement for minimally invasive composite bridges. The company was founded in 1997 and is headquartered in Turku, Finland.

Ipsat Therapies Oy develops and manufactures antibiotics & drugs. Its products include penicillins, cephalosporins and carbapenems. The firm develops products for the prevention of antibiotic resistance, antibiotic-associated diarrhea and hospital associated infections. The company was founded in 2000 and is headquartered in Helsinki, Finland.

Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland.

Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland.

DynaWell, Inc. is a privately owned, U.S. based, medical technology company. It develops, produces, markets and sells the DynaWell L-Spine, an enhanced imaging product for use by health care practitioners. The DynaWell L-Spine is designed to improve the diagnostic capabilities of Computer Tomography and Magnetic Resonance Imaging. The company was founded in 1998 and is headquartered in Las Vegas, NV.

Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden.

Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden.

Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden.

Bostadsrättsföreningen Trumslagaren 3 is a private company based in Stockholm, Sweden. The Swedish company provides property management services.

Karl Jungstedt AB provides business and management consulting services. The private company is based in Stockholm, Sweden.

DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden.